What is the main difference between Stamakort and Thymalin?

Stamakort is a Other peptide while Thymalin is a Immune peptide. Stamakort has Very Low evidence (6 sources) and Thymalin has Moderate evidence (30 sources).

Which has more clinical evidence, Stamakort or Thymalin?

Thymalin has more clinical evidence with 8 human studies compared to 0 for Stamakort. Overall, Thymalin has Moderate evidence strength while Stamakort has Very Low.

Are Stamakort and Thymalin FDA approved?

Stamakort has Very Low clinical evidence and is not FDA-approved for general use. Thymalin has moderate clinical evidence from human studies, though its regulatory status varies. Always verify current regulatory status with official sources.

Can Stamakort and Thymalin be combined?

There is no published research on combining Stamakort and Thymalin. The safety and efficacy of any combination is unknown without clinical data.

Other Comparison

Stamakort vs Thymalin

Comparison of Stamakort (Very Low evidence) and Thymalin (Moderate evidence).

Last updated: February 12, 2026

Stamakort

Very Low Evidence

View full dossier

Thymalin

Moderate Evidence

View full dossier

Overview

Stamakort and Thymalin are both studied in the peptide research space.

Stamakort: A peptide bioregulator developed by Russian scientist Vladimir Khavinson for gastric mucosa support.

Thymalin: A thymic peptide complex developed in Russia and used clinically in the former Soviet Union for immunomodulation.

Evidence Comparison

Aspect	Stamakort	Thymalin
Evidence Level	Very Low	Moderate
Human Studies	0	8
Preclinical Studies	5	22
Total Sources	6	30

Key Differences

Aspect	Stamakort	Thymalin
Category	Other	Immune
Evidence Strength	Very Low	Moderate
Total Sources	6	30
Human Studies	0	8

Summary

Stamakort: Very Low evidence with 6 total sources (0 human)
Thymalin: Moderate evidence with 30 total sources (8 human)

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.

View Full Dossiers

Stamakort Evidence Dossier Thymalin Evidence Dossier

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.